Positive Selection of Mutations in Human Cancers
Author Information
Author(s): Babenko Vladimir N, Basu Malay K, Kondrashov Fyodor A, Rogozin Igor B, Koonin Eugene V
Primary Institution: National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health
Hypothesis
Can positive selection of somatic mutations be detected in human cancers?
Conclusion
The study suggests that positive selection might affect a substantial number of genes during tumorigenic somatic evolution.
Supporting Evidence
- 112 genes showed a significant excess of non-synonymous over synonymous substitutions in tumors.
- The study identified 341 mutational hotspots in cancer ESTs.
- 42 of the 112 CASPS genes had definitive connections to tumorigenesis.
Takeaway
The study found that some genes in cancer evolve in a way that helps them grow and spread, which is like how animals adapt to survive.
Methodology
A genome-wide analysis of somatic mutations in Expressed Sequence Tags (ESTs) from tumors and normal tissues was performed.
Potential Biases
The analysis may be influenced by sequencing errors and undetected polymorphisms.
Limitations
The results should be interpreted with caution due to potential sequencing errors and the focus on highly expressed genes.
Statistical Information
P-Value
3.7 × 10-32
Statistical Significance
p < 10-7
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website